The size of the U.S. wave has given regulators and scientists an opportunity to better assess vaccine efficacy in children aged 6 months to 4 years old, said Dr. Scott Gottlieb, who sits on the board of the vaccine…
The size of the U.S. wave has given regulators and scientists an opportunity to better assess vaccine efficacy in children aged 6 months to 4 years old, said Dr. Scott Gottlieb, who sits on the board of the vaccine…